Skip to main navigation Skip to search Skip to main content

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

Translated title of the contribution: Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionHolmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
Original languageUndefined/Unknown
Pages (from-to)1025-1034
Number of pages10
JournalLANCET ONCOLOGY
Volume13
Issue number10
Publication statusPublished - 2012

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Medical sciences
  • Bescherming en bevordering van de menselijke gezondheid

Cite this